Biomerica Inc (BMRA)

Currency in USD
3.170
-0.340(-9.69%)
Closed·
3.000-0.170(-5.36%)
·
BMRA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual Post-Market activity
BMRA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.8203.220
52 wk Range
2.08010.160
Key Statistics
Prev. Close
3.51
Open
3.09
Day's Range
2.82-3.22
52 wk Range
2.08-10.16
Volume
707.5K
Average Volume (3m)
691.17K
1-Year Change
26.55%
Book Value / Share
2.41
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BMRA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Biomerica Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Biomerica Inc Company Profile

Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company’s diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops, markets, and sells COVID-19 diagnostic tests to indicate if a person has been infected by COVID-19. The company was incorporated in 1971 and is headquartered in Irvine, California.

Compare BMRA to Peers and Sector

Metrics to compare
BMRA
Peers
Sector
Relationship
P/E Ratio
−1.7x−4.1x−0.5x
PEG Ratio
−0.06−0.150.00
Price/Book
1.5x3.1x2.6x
Price / LTM Sales
1.4x2.8x3.3x
Upside (Analyst Target)
-38.6%40.1%
Fair Value Upside
Unlock14.5%5.1%Unlock

Earnings

Latest Release
Apr 14, 2025
EPS / Forecast
-0.48 / --
Revenue / Forecast
1.12M / --
EPS Revisions
Last 90 days

BMRA Income Statement

People Also Watch

7.9500
CYCC
-10.57%
57.81
BMNR
-4.37%
2.53
INMB
+3.27%
21.81
SRPT
+7.44%

FAQ

What Stock Exchange Does Biomerica Trade On?

Biomerica is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Biomerica?

The stock symbol for Biomerica is "BMRA."

What Is the Biomerica Market Cap?

As of today, Biomerica market cap is 8.07M.

What Is Biomerica's Earnings Per Share (TTM)?

The Biomerica EPS (TTM) is -2.14.

From a Technical Analysis Perspective, Is BMRA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Biomerica Stock Split?

Biomerica has split 4 times.

How Many Employees Does Biomerica Have?

Biomerica has 64 employees.

What is the current trading status of Biomerica (BMRA)?

As of 17 Aug 2025, Biomerica (BMRA) is trading at a price of 3.17, with a previous close of 3.51. The stock has fluctuated within a day range of 2.82 to 3.22, while its 52-week range spans from 2.08 to 10.16.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.